Novo Nordisk CEO Uncertain How Trump's Drug Tariffs, EU Deal Match Up -- Market Talk

Dow Jones

Sep 26

1157 GMT - It is unclear how new U.S. drug tariffs relate to a U.S.-EU trade deal capping levies, Novo Nordisk CEO Mike Doustdar says. The Danish pharma group looks forward to working with the Trump administration, but it is uncertain whether the earlier deal between the U.S. and the EU will keep tariffs at 15% rather than the 100% announced by President Trump, Doustdar writes in a statement. Construction is under way on a Novo Nordisk manufacturing site in North Carolina, he adds. Trump announced Thursday that the tariffs would hit pharmaceutical companies not building U.S. plants. Novo Nordisk shares are down 1.7%. (william.gray@wsj.com)

(END) Dow Jones Newswires

September 26, 2025 07:57 ET (11:57 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2570088814"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570088814\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570088814?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-26 19:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570088814","market":"hk","top_or_hot":-1,"title":"Novo Nordisk CEO Uncertain How Trump's Drug Tariffs, EU Deal Match Up -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1157 GMT - It is unclear how new U.S. drug tariffs relate to a U.S.-EU trade deal capping levies, <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> CEO Mike Doustdar says. The Danish pharma group looks forward to working with the Trump administration, but it is uncertain whether the earlier deal between the U.S. and the EU will keep tariffs at 15% rather than the 100% announced by President Trump, Doustdar writes in a statement. Construction is under way on a Novo Nordisk manufacturing site in North Carolina, he adds. Trump announced Thursday that the tariffs would hit pharmaceutical companies not building U.S. plants. Novo Nordisk shares are down 1.7%. (william.gray@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 26, 2025 07:57 ET (11:57 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Uncertain How Trump's Drug Tariffs, EU Deal Match Up -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Uncertain How Trump's Drug Tariffs, EU Deal Match Up -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-09-26 19:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1157 GMT - It is unclear how new U.S. drug tariffs relate to a U.S.-EU trade deal capping levies, <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> CEO Mike Doustdar says. The Danish pharma group looks forward to working with the Trump administration, but it is uncertain whether the earlier deal between the U.S. and the EU will keep tariffs at 15% rather than the 100% announced by President Trump, Doustdar writes in a statement. Construction is under way on a Novo Nordisk manufacturing site in North Carolina, he adds. Trump announced Thursday that the tariffs would hit pharmaceutical companies not building U.S. plants. Novo Nordisk shares are down 1.7%. (william.gray@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 26, 2025 07:57 ET (11:57 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0205193047.USD","symbol_name":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2570088814","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570088814","pubTimestamp":1758887820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1157 GMT - It is unclear how new U.S. drug tariffs relate to a U.S.-EU trade deal capping levies, Novo Nordisk CEO Mike Doustdar says. The Danish pharma group looks forward to working with the Trump administration, but it is uncertain whether the earlier deal between the U.S. and the EU will keep tariffs at 15% rather than the 100% announced by President Trump, Doustdar writes in a statement. Construction is under way on a Novo Nordisk manufacturing site in North Carolina, he adds. Trump announced Thursday that the tariffs would hit pharmaceutical companies not building U.S. plants. Novo Nordisk shares are down 1.7%. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","MTCH":"Match Group, Inc.","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","BK4549":"软银资本持仓","BK4588":"碎股","NVO":"诺和诺德","LU0240877869.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" ACC","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4007":"制药","BK4156":"煤与消费用燃料","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","BK4508":"社交媒体","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4532":"文艺复兴科技持仓","BK4599":"减肥药","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4077":"互动媒体与服务"},"translate_title":"诺和诺德首席执行官不确定特朗普的药品关税和欧盟协议如何匹配——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTCH":1.5,"NVO":1.5},"content_text":"1157 GMT - It is unclear how new U.S. drug tariffs relate to a U.S.-EU trade deal capping levies, Novo Nordisk CEO Mike Doustdar says. The Danish pharma group looks forward to working with the Trump administration, but it is uncertain whether the earlier deal between the U.S. and the EU will keep tariffs at 15% rather than the 100% announced by President Trump, Doustdar writes in a statement. Construction is under way on a Novo Nordisk manufacturing site in North Carolina, he adds. Trump announced Thursday that the tariffs would hit pharmaceutical companies not building U.S. plants. Novo Nordisk shares are down 1.7%. (william.gray@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 26, 2025 07:57 ET (11:57 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}